Related references
Note: Only part of the references are listed.Oxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cells
Mary C. Maj et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway
Hossein Aleyasin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Conditional transgenic mice expressing C-terminally truncated human α-synuclein (αSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons
Joao Paulo L. Daher et al.
MOLECULAR NEURODEGENERATION (2009)
A COMPARISON OF MODEL-BASED (2D) AND DESIGN-BASED (3D) STEREOLOGICAL METHODS FOR ESTIMATING CELL NUMBER IN THE SUBSTANTIA NIGRA PARS COMPACTA (SNpc) OF THE C57BL/6J MOUSE
Z. C. Baquet et al.
NEUROSCIENCE (2009)
Parkinson's disease
Bobby Thomas et al.
HUMAN MOLECULAR GENETICS (2007)
MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity
Bobby Thomas et al.
NEUROBIOLOGY OF DISEASE (2007)
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
Vincent Ries et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
β-synuclein modulates α-synuclein neurotoxicity by reducing α-synuclein protein expression
Yuxin Fan et al.
HUMAN MOLECULAR GENETICS (2006)
A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3) K-Akt signalling
Lara Fallon et al.
NATURE CELL BIOLOGY (2006)
Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice
Satoshi Ohashi et al.
NEUROSCIENCE LETTERS (2006)
Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human α-synuclein (1-120):: Implications for Lewy body disorders
GK Tofaris et al.
JOURNAL OF NEUROSCIENCE (2006)
Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling
YF Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Parkinson-like syndrome induced by continuous MPTP infusion:: Convergent roles of the ubiquitin-proteasome system and α-synuclein
F Fornai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
α-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells -: Intermediacy of transferrin receptor iron and hydrogen peroxide
SV Kalivendi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP
DD Song et al.
EXPERIMENTAL NEUROLOGY (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Risk factors for dopaminergic neuron loss in human α-synuclein transgenic mice
MJ Thiruchelvam et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
ES Emamian et al.
NATURE GENETICS (2004)
Mice lacking α-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration
RE Drolet et al.
NEUROTOXICOLOGY (2004)
Stabilization of α-synuclein protein with aging and familial Parkinson's disease-linked A53T mutation
WX Li et al.
JOURNAL OF NEUROSCIENCE (2004)
An antiaggregation gene therapy strategy for Lewy body disease utilizing β-synuclein lentivirus in a transgenic model
M Hashimoto et al.
GENE THERAPY (2004)
Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ-synuclein, α-synuclein and double α/γ-synuclein null mutant mice
DC Robertson et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Overexpression of α-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of α-synuclein and activation of caspase-9:: resemblance to pathogenetic changes in Parkinson's disease
M Yamada et al.
JOURNAL OF NEUROCHEMISTRY (2004)
β-synuclein regulates Akt activity in neuronal cells -: A possible mechanism for neuroprotection in Parkinson's disease
M Hashimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
EM Valente et al.
SCIENCE (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
β-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation -: Cross-talk with α-synuclein and implication for Parkinson's disease
CA da Costa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Nigrostriatal α-synucleinopathy induced by viral vector-mediated overexpression of human α-synuclein:: A new primate model of Parkinson's disease
D Kirik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice
S Sugama et al.
BRAIN RESEARCH (2003)
Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine-induced parkinsonism in mice
OM Schluter et al.
NEUROSCIENCE (2003)
Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease
GE Meredith et al.
BRAIN RESEARCH (2002)
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
W Dauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Overexpression of Parkinson's disease-associated α-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP
ZZ Dong et al.
JOURNAL OF NEUROBIOLOGY (2002)
Expression of mutant α-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro
V Lehmensiek et al.
NEUROREPORT (2002)
Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice
MK Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
BI Giasson et al.
NEURON (2002)
Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back
H Bergman et al.
MOVEMENT DISORDERS (2002)
Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease
E Rockenstein et al.
BRAIN RESEARCH (2001)
Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice
Christian G. Specht et al.
BMC NEUROSCIENCE (2001)
Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant α-synuclein transgenic mice
S Rathke-Hartlieb et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety
S Przedborski et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease
S Przedborski et al.
JOURNAL OF NEUROCHEMISTRY (2001)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
α-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP
M Vila et al.
JOURNAL OF NEUROCHEMISTRY (2000)
MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
NW Kowall et al.
NEUROREPORT (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation
S Kanda et al.
NEUROSCIENCE (2000)
Share Paper
